ATE202923T1 - Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle - Google Patents

Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle

Info

Publication number
ATE202923T1
ATE202923T1 AT96920480T AT96920480T ATE202923T1 AT E202923 T1 ATE202923 T1 AT E202923T1 AT 96920480 T AT96920480 T AT 96920480T AT 96920480 T AT96920480 T AT 96920480T AT E202923 T1 ATE202923 T1 AT E202923T1
Authority
AT
Austria
Prior art keywords
beneficial agent
oral
dosage form
oral dosage
pain
Prior art date
Application number
AT96920480T
Other languages
English (en)
Inventor
Joyce C Anthony
Liang C Dong
Susan M Marks
Danusia Szumowski
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE202923T1 publication Critical patent/ATE202923T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
AT96920480T 1995-06-07 1996-05-24 Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle ATE202923T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/475,233 US5713852A (en) 1995-06-07 1995-06-07 Oral dosage and method for treating painful conditions of the oral cavity
PCT/US1996/007668 WO1996040050A1 (en) 1995-06-07 1996-05-24 Oral dosage and method for treating painful conditions of the oral cavity

Publications (1)

Publication Number Publication Date
ATE202923T1 true ATE202923T1 (de) 2001-07-15

Family

ID=23886750

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96920480T ATE202923T1 (de) 1995-06-07 1996-05-24 Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle

Country Status (7)

Country Link
US (1) US5713852A (de)
EP (1) EP0831774B1 (de)
JP (1) JP3973684B2 (de)
AT (1) ATE202923T1 (de)
AU (1) AU5876596A (de)
DE (1) DE69613840T2 (de)
WO (1) WO1996040050A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9419001D0 (en) * 1994-09-21 1994-11-09 Applied Research Systems Assay method
US6060534A (en) 1996-07-11 2000-05-09 Scimed Life Systems, Inc. Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties
US6319510B1 (en) 1999-04-20 2001-11-20 Alayne Yates Gum pad for delivery of medication to mucosal tissues
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
US20030190360A1 (en) * 2001-03-13 2003-10-09 Baichwal Anand R. Chronotherapeutic dosage forms containing glucocorticosteroid and methods of treatment
EP1446167A4 (de) * 2001-11-05 2010-09-29 Orahealth Corp Behandlung von geschwüren mit pflastern zur beschleunigung der heilung und linderung von schmerzen
US7201930B2 (en) 2001-11-05 2007-04-10 Haley Jeffrey T Licorice root extract oral patch for treating canker sores
US20030124178A1 (en) * 2001-12-28 2003-07-03 Haley Jeffrey T. Soft, adherent, soluble oral patch
US20050226915A1 (en) * 2001-12-28 2005-10-13 Oramelts Corporation, A Washington Corporation Method for manufacturing and packaging oral patches with rounded edges
US20050208135A1 (en) * 2002-05-06 2005-09-22 Narayanan Badri Viswanathan Monocompartment osmotic controlled drug delivery system
US20050118267A1 (en) * 2003-09-19 2005-06-02 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
NZ545921A (en) * 2003-09-19 2009-09-25 Penwest Pharmaceuticals Co Delayed released dosage forms
WO2006030402A2 (en) * 2004-09-17 2006-03-23 Ranbaxy Laboratories Limited Dual compartment osmotic delivery device
DE102004050591A1 (de) * 2004-09-22 2006-04-06 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Schleimdrogenbasierte Lutschtablette gegen entzündliche Erkrankungen des Mund- und Rachenraums
WO2006046114A2 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Osmotic dosage forms providing ascending drug release, and processes for their preparation
US20060134201A1 (en) * 2004-12-16 2006-06-22 Haley Jeffrey T Collagen troches for treating mouth lesions
US8349120B2 (en) * 2006-03-07 2013-01-08 Ora Health Corporation Multi-layer patch made on a sheet and enclosed in a blister
US20070248655A1 (en) * 2006-04-21 2007-10-25 Haley Jeffrey T Lenticular shaped protective mouth sore discs
US20070248654A1 (en) * 2006-04-21 2007-10-25 Haley Jeffrey T Protective mouth sore discs made with corn starch
US8701671B2 (en) 2011-02-04 2014-04-22 Joseph E. Kovarik Non-surgical method and system for reducing snoring
US9549842B2 (en) 2011-02-04 2017-01-24 Joseph E. Kovarik Buccal bioadhesive strip and method of treating snoring and sleep apnea
US20120083763A1 (en) * 2010-10-04 2012-04-05 Diaz Edwin A Method for Delivering a Topical Agent to a Nasaogastric Passage
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
PL2701681T3 (pl) 2011-04-29 2017-03-31 Moberg Pharma Ab Kompozycje farmaceutyczne zawierające środek miejscowo znieczulający, taki jak bupiwakaina, do podawania miejscowego do jamy ustnej lub gardła
EP2742931A1 (de) 2012-12-13 2014-06-18 LTS LOHMANN Therapie-Systeme AG Topisches Arzneimittel zur Behandlung von Aphten
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US10758329B1 (en) 2019-08-20 2020-09-01 Raymond L. Wright, III Hydrating mouth guard

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1171691A (en) * 1967-02-24 1969-11-26 Forest Laboratories Lond-Acting Oral Carrier
US3625214A (en) * 1970-05-18 1971-12-07 Alza Corp Drug-delivery device
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4111203A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system with means for improving delivery kinetics of system
US4203439A (en) * 1976-11-22 1980-05-20 Alza Corporation Osmotic system with volume amplifier for increasing amount of agent delivered therefrom
US4111201A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for delivering selected beneficial agents having varying degrees of solubility
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4186184A (en) * 1977-12-27 1980-01-29 Alza Corporation Selective administration of drug with ocular therapeutic system
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4309996A (en) * 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4800056A (en) * 1984-03-21 1989-01-24 Alza Corporation Process for making dispenser with cooperating elements
EP0159604B1 (de) * 1984-04-09 1990-11-07 Toyo Boseki Kabushiki Kaisha Präparat mit verzögerter Freigabe zum Aufbringen auf die Schleimhäute der Mundhöhle
JPH0729915B2 (ja) * 1986-02-01 1995-04-05 帝國製薬株式会社 シ−ト状口腔内貼付剤
US4971790A (en) * 1986-02-07 1990-11-20 Alza Corporation Dosage form for lessening irritation of mocusa
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
US4940465A (en) * 1987-05-27 1990-07-10 Felix Theeuwes Dispenser comprising displaceable matrix with solid state properties
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4900552A (en) * 1988-03-30 1990-02-13 Watson Laboratories, Inc. Mucoadhesive buccal dosage forms
US4917894A (en) * 1988-06-29 1990-04-17 Beecham Inc. Rapid-onset long-duration oral anesthetic composition
US5019396A (en) * 1989-05-12 1991-05-28 Alza Corporation Delivery dispenser for treating cardiac arrhythmias
US5021053A (en) * 1989-07-14 1991-06-04 Alza Corporation Oral osmotic device with hydrogel driving member
US5057321A (en) * 1990-06-13 1991-10-15 Alza Corporation Dosage form comprising drug and maltodextrin
US5200195A (en) * 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
US5248310A (en) * 1992-03-27 1993-09-28 Alza Corporation Oral osmotic device with hydrogel driving member
US5298256A (en) * 1992-04-28 1994-03-29 Corint, Ltd. Desmopressin buccal patch composition
CA2093282C (en) * 1992-05-04 1999-01-12 Tibor Sipos Intraoral medicament-releasing device
US5512293A (en) * 1992-07-23 1996-04-30 Alza Corporation Oral sustained release drug delivery device
US5573776A (en) * 1992-12-02 1996-11-12 Alza Corporation Oral osmotic device with hydrogel driving member
US5520924A (en) * 1993-07-09 1996-05-28 Mizu Systems Corporation Methods and articles for administering drug to the oral cavity
US5578315A (en) * 1993-12-01 1996-11-26 Rutgers, The State University Of New Jersey Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity
GB9325737D0 (en) * 1993-12-16 1994-02-23 British Airospace Public Limit Link apparatus

Also Published As

Publication number Publication date
EP0831774B1 (de) 2001-07-11
EP0831774A1 (de) 1998-04-01
DE69613840D1 (de) 2001-08-16
JP2001515456A (ja) 2001-09-18
WO1996040050A1 (en) 1996-12-19
AU5876596A (en) 1996-12-30
JP3973684B2 (ja) 2007-09-12
DE69613840T2 (de) 2002-04-04
US5713852A (en) 1998-02-03

Similar Documents

Publication Publication Date Title
ATE202923T1 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
DE69736745D1 (de) Verfahren zur behandlung von prostaterkrankungen unter verwendung von vitamin-d-formulierungen mit verzögerter und/oder verlängerter wirkstofffreigabe
ATE321529T1 (de) Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
MD1663B2 (en) Composition and methods for human sexual activity modulation and impotency treatment
ATE237330T1 (de) Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung
DK0880350T3 (da) Behandling af dissemineret sklerose
ES2166783T3 (es) Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii.
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
ATE119386T1 (de) Äusserlich anzuwendende analgetische lotion und verfahren zur herstellung.
DE60029591D1 (de) Konjugierte linolensäure zur behandlung von cyclooxygenase-2 vermittelten entzündungen und schmerzen
ATE146677T1 (de) Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit
ATE267583T1 (de) Arzneizubereitungen zur behandlung sexueller funktionsstörungen
MXPA02012075A (es) Composicion para mediar el dolor y aparato y metodo para utilizarla.
HK1037980A1 (en) Use of selegiline or desmethylselegiline for the manufacture of a medicament for treating wounds, burns or photodamage.
CA2156481A1 (en) 5-ht2 receptor antagonist compositions useful in treating venous conditions
AR003979A1 (es) Administracion transdermica de vorozol.
DE69917756D1 (de) Methoden zur behandlung von neurombedingten schmerzen
DE69304266D1 (de) Zusammensetzung enthaltend Dibucaine-Hydrochlorid, ein Salicylat, Calciumbromid und ein antiphlogistisches steroid zur Schmerzbekämpfung
CY1108368T1 (el) Διαδερμικη συσκευη φελοδιπινης και μεθοδοι
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch
ATE218869T1 (de) Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen
PL325557A1 (en) Agent for use in prophylactics and/or treatmet of human and animal hair loss
EA199700034A2 (ru) Способ в.г.соломатова коррекции энергетического состояния живого существа
TNSN03022A1 (en) Method for treatment of inflammation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties